Publication | Closed Access
690P Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study
18
Citations
0
References
2023
Year
Phase I/ii StudyMedicinePathologyAdvanced Solid TumorsBiomarker ResultsOncologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!